Robert Langer - Net Worth and Insider Trading

Robert Langer Net Worth

The estimated net worth of Robert Langer is at least $0 dollars as of 2024-03-29. Robert Langer is the Director of Rubius Therapeutics Inc and owns about 0 shares of Rubius Therapeutics Inc (RUBY) stock worth over $0. Details can be seen in Robert Langer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert Langer has not made any transactions after 2019-10-14 and currently still holds the listed stock(s).

Transaction Summary of Robert Langer

To

Robert Langer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Langer owns 17 companies in total, including Frequency Therapeutics Inc () , Lyra Therapeutics Inc () , and Moderna Inc () among others .

Click here to see the complete history of Robert Langer’s form 4 insider trades.

Insider Ownership Summary of Robert Langer

Ticker Comapny Transaction Date Type of Owner
Frequency Therapeutics Inc 2019-10-02 director
Lyra Therapeutics Inc 2020-04-30 director
Moderna Inc 2018-12-07 director
Rubius Therapeutics Inc 2019-10-14 director
Kala Bio Inc 2017-07-19 director & 10 percent owner
Abpro Corp 2018-05-10 director
DNIB Unwind Inc 2016-08-26 director
Cartesian Therapeutics Inc 2016-06-21 10 percent owner
Ocata Therapeutics Inc 2016-02-10 director
InVivo Therapeutics Holdings Corp 2010-10-26 10 percent owner
Fibrocell Science Inc 2011-01-14 director
Echo Therapeutics Inc 2009-12-11 director
Alseres Pharmaceuticals Inc 2009-01-14 director
Momenta Pharmaceuticals Inc 2008-08-08 director
SQZ Biotechnologies Co 2020-10-29 10 percent owner
Seer Inc 2021-06-17 director
Korro Bio Inc 2019-10-02 director

Robert Langer Latest Holdings Summary

Robert Langer currently owns a total of 1 stock. Robert Langer owns 0 shares of Rubius Therapeutics Inc (RUBY) as of October 14, 2019, with a value of $0.

Latest Holdings of Robert Langer

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RUBY Rubius Therapeutics Inc 2019-10-14 0 0.06 0

Holding Weightings of Robert Langer


Robert Langer Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Langer has made a total of 3 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Rubius Therapeutics Inc is the sale of 7,500 shares on October 14, 2019, which brought Robert Langer around $63,900.

Insider Trading History of Robert Langer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Langer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Langer Ownership Network

Ownership Network List of Robert Langer

No Data

Ownership Network Relation of Robert Langer


Robert Langer Owned Company Details

What does Frequency Therapeutics Inc do?

Who are the key executives at Frequency Therapeutics Inc?

Robert Langer is the director of Frequency Therapeutics Inc. Other key executives at Frequency Therapeutics Inc include director & President and CEO David L. Lucchino , VP Finance & Operations Richard J. Mitrano , and Chief Scientific Officer Christopher R. Loose .

Frequency Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Robert Langer made no insider transaction in Frequency Therapeutics Inc (). Other recent insider transactions involving Frequency Therapeutics Inc () include a net sale of 97,675 shares made by David L. Lucchino , a net sale of 8,202 shares made by Richard J. Mitrano , and a net sale of 26,723 shares made by Christopher R. Loose .

In summary, during the past 3 months, insiders sold 0 shares of Frequency Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,600 shares of Frequency Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,600 shares.

Frequency Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Frequency Therapeutics Inc Insider Transactions

No Available Data

Robert Langer Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Langer. You might contact Robert Langer via mailing address: 98 Montvale Rd, Newton Ma 02459.

Discussions on Robert Langer

No discussions yet.